| Phase 12 trials |
|
Phase 1
|
NCT01269255 |
Dec 2009 → Jan 2012 |
gastric cancer |
Yonsei University |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01131689 |
Sep 2009 → Sep 2010 |
hepatocellular carcinoma |
Samsung Medical Center |
Completed
|
No outcome recorded
|
| Phase 1/23 trials |
|
Phase 1/2
|
NCT00874328 |
Oct 2008 → Dec 2011 |
non-small cell lung carcinoma |
National Cancer Center, Korea |
Unknown
|
No outcome recorded
|
|
Phase 1/2
|
NCT00531245 |
Aug 2006 → Jun 2008 |
colorectal neoplasm |
Samsung Medical Center |
Completed
|
No outcome recorded
|
|
Phase 1/2
|
NCT00209729 |
Apr 2005 → Dec 2009 |
gastric cancer |
Hokkaido Gastrointestinal Cancer Study Group |
Suspended
|
No outcome recorded
|
| Phase 29 trials |
|
Phase 2
|
NCT03559348 |
Apr 2018 → Apr 2020 |
pancreatic adenocarcinoma |
National Health Research Institutes, Taiwan |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT03382600 |
Mar 2018 → May 2021 |
gastric cancer |
Merck Sharp & Dohme LLC |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT03814759 |
Dec 2016 → Dec 2021 |
gastric adenocarcinoma |
Yonsei University |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT03519074 |
Jul 2016 → Sep 2024 overdue |
cancer, liver disorder |
National University Hospital, Singapore |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT02754180 |
Mar 2016 → Mar 2019 |
malignant exocrine pancreas neoplasm |
Peking Union Medical College Hospital |
Unknown
|
No outcome recorded
|
|
Phase 2
|
NCT01171755 |
Feb 2008 → Dec 2009 |
biliary tract cancer |
Samsung Medical Center |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT00512681 |
Jul 2007 → Jul 2009 |
gastric neoplasm |
National Cancer Center, Korea |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00436423 |
Mar 2006 → ? |
metastatic neoplasm, pancreatic neoplasm |
Korea University Anam Hospital |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00209651 |
Jan 2004 → Dec 2007 |
colorectal cancer |
Hokkaido Gastrointestinal Cancer Study Group |
Unknown
|
No outcome recorded
|
| Phase 2/32 trials · 1 met primary |
|
Phase 2/3
|
NCT05065957 |
Mar 2022 → Jul 2026 overdue |
biliary tract cancer |
InnoPharmax Inc. |
Recruiting
|
No outcome recorded
|
|
Phase 2/3
|
NCT00284258 |
Jan 2006 → Jul 2010 |
colorectal cancer |
Taiho Pharmaceutical Co., Ltd. |
Completed
|
Met primary
|
| Phase 35 trials |
|
Phase 3
|
NCT01761461 |
Feb 2013 → Dec 2020 |
gastric cancer |
Samsung Medical Center |
Unknown
|
No outcome recorded
|
|
Phase 3
|
NCT00498225 |
Jul 2007 → Jul 2011 |
malignant pancreatic neoplasm |
Taiho Pharmaceutical Co., Ltd. |
Completed
|
Mixed
|
|
Phase 3
|
NCT00316745 |
Apr 2006 → Mar 2009 |
colorectal cancer |
Hokkaido Gastrointestinal Cancer Study Group |
Suspended
|
No outcome recorded
|
|
Phase 3
|
NCT00252161 |
Nov 2005 → Apr 2015 |
gastric neoplasm |
Haruhiko Fukuda |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00195572 |
May 2002 → Aug 2008 |
gastric cancer |
Wyeth is now a wholly owned subsidiary of Pfizer |
Completed
|
No outcome recorded
|
| Phase not applicable1 trial |
| — |
NCT01874678 |
Mar 2011 → Dec 2015 |
non-small cell lung carcinoma |
TTY Biopharm |
Completed
|
No outcome recorded
|
| Comparator or background therapy6 trials |
|
Phase 1
|
NCT03252808 Background |
Sep 2017 → Feb 2020 overdue |
pancreatic ductal adenocarcinoma |
Takara Bio Inc. |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT04172402 Background |
Dec 2019 → Dec 2024 |
biliary tract cancer |
National Health Research Institutes, Taiwan |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01100801 Background |
Jul 2010 → Dec 2017 |
gastric cancer |
National University Hospital, Singapore |
Unknown
|
No outcome recorded
|
|
Phase 2
|
NCT01283204 Comparator |
Mar 2010 → Jul 2016 |
— |
Yonsei University |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01269216 Comparator |
Oct 2008 → Sep 2014 |
rectal cancer |
Yonsei University |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00150670 Comparator |
Mar 2002 → Dec 2006 |
gastric cancer |
Taiho Pharmaceutical Co., Ltd. |
Completed
|
Met primary
|
|